| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
5,899 |
4,982 |
$347K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,520 |
5,178 |
$168K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,202 |
2,848 |
$165K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,516 |
2,250 |
$96K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,542 |
1,351 |
$96K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,323 |
1,065 |
$79K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,814 |
1,650 |
$75K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,352 |
399 |
$71K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
747 |
690 |
$53K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,181 |
3,499 |
$52K |
| A0425 |
Ground mileage, per statute mile |
653 |
428 |
$50K |
| 36415 |
Collection of venous blood by venipuncture |
7,236 |
5,670 |
$48K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
661 |
624 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,891 |
1,759 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,530 |
1,239 |
$39K |
| 80061 |
Lipid panel |
1,160 |
1,101 |
$35K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
161 |
118 |
$35K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,318 |
2,018 |
$34K |
| 80305 |
|
885 |
802 |
$27K |
| 83735 |
|
881 |
735 |
$19K |
| 83721 |
|
948 |
900 |
$18K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
120 |
103 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
503 |
409 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
200 |
180 |
$10K |
| 84484 |
|
214 |
143 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,230 |
1,006 |
$7K |
| 80050 |
General health panel |
43 |
43 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
787 |
752 |
$6K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
149 |
141 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
120 |
102 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
136 |
117 |
$5K |
| 83605 |
|
144 |
121 |
$4K |
| 81003 |
|
791 |
678 |
$4K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
16 |
13 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
87 |
78 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
140 |
87 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
258 |
240 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
65 |
50 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
89 |
79 |
$2K |
| 84481 |
|
29 |
28 |
$2K |
| 82607 |
|
69 |
65 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
48 |
46 |
$1K |
| 97010 |
|
230 |
63 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
168 |
122 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
197 |
181 |
$1K |
| 84439 |
|
14 |
14 |
$613.44 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13 |
12 |
$558.11 |
| 82550 |
|
16 |
13 |
$427.17 |
| 86376 |
|
12 |
12 |
$294.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
88 |
74 |
$272.01 |
| 94761 |
|
15 |
13 |
$104.15 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
61 |
56 |
$47.74 |
| 82746 |
|
13 |
12 |
$19.37 |